Endocarditis: An overview of serious cardiac disease for healthcare professionals
Keywords:
Infective endocarditis, healthcare-associated infective endocarditis, Staphylococcus aureus, epidemiology, diagnosis, managementAbstract
Background: Infective endocarditis (IE) is a severe cardiac condition primarily caused by various pathogens, including bacteria and fungi, that invade the bloodstream and affect heart valves. Historically linked to rheumatic fever, the epidemiology of IE has evolved, with healthcare-associated infective endocarditis (HCAIE) now representing a significant portion of cases due to increased use of intravenous devices. Despite advances in diagnosis and treatment, mortality rates remain high, emphasizing the need for a comprehensive understanding of IE. Aim: This article aims to evaluate the epidemiological trends of IE, discuss the latest diagnostic and management guidelines, and explore future directions to improve treatment outcomes. Methods: A thorough review of recent literature, epidemiological data, and current guidelines related to IE was conducted, analyzing global trends, causative agents, risk factors, and changing prevention strategies. Results: The incidence of IE has increased significantly, from 478,000 cases in 1990 to over 1 million in 2019, with a corresponding rise in mortality. Staphylococcus aureus has emerged as the leading pathogen, particularly in healthcare settings, while the epidemiology varies across regions, especially in developing countries. Conclusion: The multifaceted nature of IE requires a multidisciplinary approach for effective management.
Downloads
References
Shmueli, H., Thomas, F., Flint, N., Setia, G., Janjic, A., & Siegel, R. J. (2020). Right-sided infective endocarditis 2020: Challenges and updates in diagnosis and treatment. Journal of the American Heart Association, 9(2020), Article e017293. https://doi.org/10.1161/JAHA.120.017293 DOI: https://doi.org/10.1161/JAHA.120.017293
El-Dalati, S., Cronin, D., Shea, M., et al. (2020). Clinical practice update on infectious endocarditis. American Journal of Medicine, 133, 44-49. https://doi.org/10.1016/j.amjmed.2019.08.022 DOI: https://doi.org/10.1016/j.amjmed.2019.08.022
Hajsadeghi, S., Hassanzadeh, M., Hajahmadi, M., & Kadivar, M. (2018). Concurrent diagnosis of infective endocarditis and acute rheumatic fever: A case report. Journal of Cardiology Cases, 17, 147-150. https://doi.org/10.1016/j.jccase.2017.12.011 DOI: https://doi.org/10.1016/j.jccase.2017.12.011
Rajani, R., & Klein, J. L. (2020). Infective endocarditis: A contemporary update. Clinical Medicine (London), 20, 31-35. https://doi.org/10.7861/clinmed.cme.20.1.1 DOI: https://doi.org/10.7861/clinmed.cme.20.1.1
Li, Z., Lin, L., Wu, H., Yan, L., Wang, H., Yang, H., & Li, H. (2021). Global, regional, and national death, and disability-adjusted life-years (DALYs) for cardiovascular disease in 2017 and trends and risk analysis from 1990 to 2017 using the global burden of disease study and implications for prevention. Frontiers in public health, 9, 559751. DOI: https://doi.org/10.3389/fpubh.2021.559751
Tleyjeh, I. M., & Bin Abdulhak, A. A. (2018). Epidemiology and global burden of infective endocarditis. In ESC CardioMed (3rd ed.). https://doi.org/10.1093/med/9780198784906.001.0001 DOI: https://doi.org/10.1093/med/9780198784906.003.0067
Sunil, M., Huynh, Q. H., Ramesh, S., et al. (2019). Evolving trends in infective endocarditis in a developing country: A consequence of medical progress? Annals of Clinical Microbiology and Antimicrobials, 18, 43. https://doi.org/10.1186/s12941-019-0341-x
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016). Infective endocarditis. Nature Reviews Disease Primers, 2, 16059. https://doi.org/10.1038/nrdp.2016.59 DOI: https://doi.org/10.1038/nrdp.2016.59
Selton-Suty, C., Célard, M., Le Moing, V., et al. (2012). Preeminence of Staphylococcus aureus in infective endocarditis: A 1-year population-based survey. Clinical Infectious Diseases, 54(9), 1230-1239. https://doi.org/10.1093/cid/cis199 DOI: https://doi.org/10.1093/cid/cis199
Thornhill, M. H., Jones, S., Prendergast, B., et al. (2018). Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. European Heart Journal, 39, 586-595. https://doi.org/10.1093/eurheartj/ehx655 DOI: https://doi.org/10.1093/eurheartj/ehx655
Sy, R. W., & Kritharides, L. (2010). Health care exposure and age in infective endocarditis: Results of a contemporary population-based profile of 1536 patients in Australia. European Heart Journal, 31, 1890-1897. https://doi.org/10.1093/eurheartj/ehq110 DOI: https://doi.org/10.1093/eurheartj/ehq110
Fedeli, U., Schievano, E., Buonfrate, D., Pellizzer, G., & Spolaore, P. (2011). Increasing incidence and mortality of infective endocarditis: A population-based study through a record-linkage system. BMC Infectious Diseases, 11, 48. https://doi.org/10.1186/1471-2334-11-48 DOI: https://doi.org/10.1186/1471-2334-11-48
Toyoda, N., Chikwe, J., Itagaki, S., Gelijns, A. C., Adams, D. H., & Egorova, N. N. (2017). Trends in infective endocarditis in California and New York State, 1998-2013. JAMA, 317, 1652-1660. https://doi.org/10.1001/jama.2017.4287 DOI: https://doi.org/10.1001/jama.2017.4287
Mostaghim, A. S., Lo, H. Y. A., & Khardori, N. (2017). A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital. SAGE Open Medicine, 5, Article 2050312117741772. https://doi.org/10.1177/2050312117741772 DOI: https://doi.org/10.1177/2050312117741772
Murdoch, D. R., Corey, G. R., Hoen, B., et al. (2009). Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The international collaboration on endocarditis-prospective cohort study. Archives of Internal Medicine, 169, 463-473. https://doi.org/10.1001/archinternmed.2008.603 DOI: https://doi.org/10.1001/archinternmed.2008.603
Fernandez-Hidalgo, N., Almirante, B., Tornos, P., et al. (2008). Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clinical Infectious Diseases, 47, 1287-1297. https://doi.org/10.1086/592576 DOI: https://doi.org/10.1086/592576
Parikh, M. P., Octaria, R., & Kainer, M. A. (2020). Methicillin-resistant bloodstream infections and injection drug use, Tennessee, USA, 2015–2017. Emerging Infectious Diseases, 26, 446-453. https://doi.org/10.3201/eid2603.191408 DOI: https://doi.org/10.3201/eid2603.191408
Wilson, W., Taubert, K. A., Gewitz, M., et al. (2007). Prevention of infective endocarditis: Guidelines from the American Heart Association. Circulation, 116, 1736-1754. https://doi.org/10.1161/CIRCULATIONAHA.106.183095 DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.183095
Suda, K. J., Calip, G. S., Zhou, J., et al. (2019). Assessment of the appropriateness of antibiotic prescriptions for infection prophylaxis before dental procedures, 2011 to 2015. JAMA Network Open, 2, Article e193909. https://doi.org/10.1001/jamanetworkopen.2019.3909 DOI: https://doi.org/10.1001/jamanetworkopen.2019.3909
Dayer, M. J., Jones, S., Prendergast, B., Baddour, L. M., Lockhart, P. B., & Thornhill, M. H. (2015). Incidence of infective endocarditis in England, 2000-13: A secular trend, interrupted time-series analysis. The Lancet, 385, 1219-1228. https://doi.org/10.1016/S0140-6736(14)62007-9 DOI: https://doi.org/10.1016/S0140-6736(14)62007-9
Garg, P., Ko, D. T., Bray Jenkyn, K. M., et al. (2019). Infective endocarditis hospitalizations and antibiotic prophylaxis rates before and after the 2007 American Heart Association guideline revision. Circulation, 140, 170-180. https://doi.org/10.1161/CIRCULATIONAHA.118.037657 DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.037657
Thornhill, M. H., Dayer, M. J., Forde, J. M., et al. (2011). Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: Before and after study. BMJ, 342, d2392. https://doi.org/10.1136/bmj.d2392 DOI: https://doi.org/10.1136/bmj.d2392
Sunil, M., Hieu, H. Q., Singh, R. A., Ponnampalavanar, S., Siew, K. S. W., & Loch, A. (2019). Evolving trends in infective endocarditis in a developing country: A consequence of medical progress? Annals of Clinical Microbiology and Antimicrobials, 18, 43. https://doi.org/10.1186/s12941-019-0341-x DOI: https://doi.org/10.1186/s12941-019-0341-x
Millar, B. C., Habib, G., & Moore, J. E. (2016). New diagnostic approaches in infective endocarditis. Heart, 102(10), 796-807. https://doi.org/10.1136/heartjnl-2014-307021
Maisch, B. (2016). ESC/AHA-Endokarditisleitlinien 2015: Wettstreit oder Gleichklang? [ESC and AHA guidelines 2015 on endocarditis: In competition or synchrony?] Herz, 41, 690-696. https://doi.org/10.1007/s00059-016-4494-5 DOI: https://doi.org/10.1007/s00059-016-4494-5
Saraste, A., & Knuuti, J. (2019). Guidelines in review: Comparison of ESC and AHA guidance for the diagnosis and management of infective endocarditis in adults. Are the differences clinically relevant? The European perspective. Journal of Nuclear Cardiology, 26(2), 309-312. https://doi.org/10.1007/s12350-018-1414-5 DOI: https://doi.org/10.1007/s12350-018-1414-5
Durack, D. T. (1998). Approach to diagnosis of infective endocarditis. Clinical Microbiology and Infection, 4(3), S3-S9. https://doi.org/10.1111/j.1469-0691.1998.tb00861.x DOI: https://doi.org/10.1111/j.1469-0691.1998.tb00861.x
Davierwala, P. M., Marin-Cuartas, M., Misfeld, M., & Borger, M. A. (2019). The value of an “Endocarditis Team.” Annals of Cardiothoracic Surgery, 8(6), 621-629. https://doi.org/10.21037/acs.2019.09.03 DOI: https://doi.org/10.21037/acs.2019.09.03
Millar, B. C., Habib, G., & Moore, J. E. (2016). New diagnostic approaches in infective endocarditis. Heart, 102(10), 796-807. https://doi.org/10.1136/heartjnl-2014-307021
Camou, F., Dijos, M., Barandon, L., et al. (2019). Management of infective endocarditis and multidisciplinary approach. Médecine et Maladies Infectieuses, 49(1), 17-22. https://doi.org/10.1016/j.medmal.2018.06.007 DOI: https://doi.org/10.1016/j.medmal.2018.06.007
Mestres, C. A., Paré, J. C., & Miró, J. M. (2015). Organization and functioning of a multidisciplinary team for the diagnosis and treatment of infective endocarditis: A 30-year perspective (1985-2014). Revista Española de Cardiología, 68(5), 363-368. https://doi.org/10.1016/j.rec.2014.10.006 DOI: https://doi.org/10.1016/j.rec.2014.10.006
El-Dalati, S., Cronin, D., Riddell, J., et al. (2021). A step-by-step guide to implementing a multidisciplinary endocarditis team. Therapeutic Advances in Infectious Disease, 8, 204993612110655. https://doi.org/10.1177/20499361211065596 DOI: https://doi.org/10.1177/20499361211065596
Ruch, Y., Mazzucotelli, J. P., Lefebvre, F., et al. (2019). Impact of setting up an “endocarditis team” on the management of infective endocarditis. Open Forum Infectious Diseases, 6(4), ofz308. https://doi.org/10.1093/ofid/ofz308 DOI: https://doi.org/10.1093/ofid/ofz308
Regunath, H., Vasudevan, A., Vyas, K., et al. (2019). A quality improvement initiative: Developing a multidisciplinary team for infective endocarditis. Missouri Medicine, 116(4), 291-296. https://pubmed.ncbi.nlm.nih.gov/31527977/
Habib, G., Badano, L., Tribouilloy, C., et al. (2010). Recommendations for the practice of echocardiography in infective endocarditis. European Journal of Echocardiography, 11(3), 202-219. https://doi.org/10.1093/ejechocard/jeq004 DOI: https://doi.org/10.1093/ejechocard/jeq004
Horgan, S. J., Mediratta, A., & Gillam, L. D. (2020). Cardiovascular imaging in infective endocarditis: A multimodality approach. Circulation: Cardiovascular Imaging, 13(7), Article e008956. https://doi.org/10.1161/CIRCIMAGING.120.008956 DOI: https://doi.org/10.1161/CIRCIMAGING.120.008956
Murillo, H., Restrepo, C. S., Marmol-Velez, J. A., et al. (2016). Infectious diseases of the heart: Pathophysiology, clinical and imaging overview. Radiographics, 36(4), 963-983. https://doi.org/10.1148/rg.2016150225 DOI: https://doi.org/10.1148/rg.2016150225
Cahill, T. J., Baddour, L. M., Habib, G., et al. (2017). Challenges in infective endocarditis. Journal of the American College of Cardiology, 69(3), 325-344. https://doi.org/10.1016/j.jacc.2016.10.066 DOI: https://doi.org/10.1016/j.jacc.2016.10.066
Millar, B. C., Habib, G., & Moore, J. E. (2016). New diagnostic approaches in infective endocarditis. Heart, 102(10), 796-807. https://doi.org/10.1136/heartjnl-2014-307021 DOI: https://doi.org/10.1136/heartjnl-2014-307021
Lancellotti, P., Pibarot, P., Chambers, J., et al. (2016). Recommendations for the imaging assessment of prosthetic heart valves: A report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. European Heart Journal - Cardiovascular Imaging, 17(6), 589-590. https://doi.org/10.1093/ehjci/jew025 DOI: https://doi.org/10.1093/ehjci/jew025
Saeedan, M. B., Wang, T. K. M., Cremer, P., et al. (2021). Role of cardiac CT in infective endocarditis: Current evidence, opportunities, and challenges. Radiology: Cardiothoracic Imaging, 3(1), Article e200378. https://doi.org/10.1148/ryct.2021200378 DOI: https://doi.org/10.1148/ryct.2021200378
Habib, G., Lancellotti, P., Antunes, M. J., et al. (2015). 2015 ESC Guidelines for the management of infective endocarditis: The task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal, 36(44), 3075-3128. https://doi.org/10.1093/eurheartj/ehv319 DOI: https://doi.org/10.1093/eurheartj/ehv319
Feuchtner, G. M., Stolzmann, P., Dichtl, W., et al. (2009). Multislice computed tomography in infective endocarditis: Comparison with transesophageal echocardiography and intraoperative findings. Journal of the American College of Cardiology, 53(5), 436-444. https://doi.org/10.1016/j.jacc.2008.01.077 DOI: https://doi.org/10.1016/j.jacc.2008.01.077
Bruun, N. E., Habib, G., Thuny, F., & Sogaard, P. (2014). Cardiac imaging in infectious endocarditis. European Heart Journal, 35(11), 624-632. https://doi.org/10.1093/eurheartj/eht274 DOI: https://doi.org/10.1093/eurheartj/eht274
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
